Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative disease
Recent advances in gene-editing technologies offer new opportunities for drug development to treat unmet medical needs in central nervous system (CNS) disorders including neurogenerative diseases of the aging brain. The adeno-associated virus (AAV) is a promising and most widely utilized vector for...
Saved in:
| Main Authors: | Boris Kantor, Bernadette O'Donovan, Ornit Chiba-Falek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Molecular Therapy: Nucleic Acids |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253125001891 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Applications of CRISPR-Cas-Based Genome Editing Approaches Against Human Cytomegalovirus Infection
by: Andra Zhang, et al.
Published: (2025-06-01) -
CRISPR-Cas9 system in autosomal dominant polycystic kidney disease: a comprehensive review
by: Seungyeon Kang, et al.
Published: (2025-02-01) -
Biosafety considerations triggered by genome-editing technologies
by: Xinxin Li, et al.
Published: (2025-06-01) -
Innovations and implementations of clustered regularly interspaced short palindromic repeats in next-generation diagnostic tools: A review of current and emerging techniques
by: Samudrala Lahari, et al.
Published: (2025-01-01) -
Emerging applications of gene editing technologies for the development of climate-resilient crops
by: R. L. Chavhan, et al.
Published: (2025-03-01)